Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02551055
Title MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Lake Success New York United States Details
New York New York United States Details
Philadelphia Pennsylvania United States Details
Dallas Texas United States Details
Houston Texas United States Details
Barcelona Spain Details
*Shaded cells indicate that there was no data available from for the field